Trial Search Results

Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

This research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors. Study biospecimen samples from osteosarcoma survivors in the laboratory may help doctors learn whether chemotherapy causes fertility problems and to learn more about the long term effects.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Children's Oncology Group

Collaborator: National Cancer Institute (NCI)

Stanford Investigator(s):

Intervention(s):

  • Procedure: Biospecimen Collection
  • Other: Laboratory Biomarker Analysis
  • Other: Questionnaire Administration

Eligibility


Inclusion Criteria:

   - Received upfront therapies for osteosarcoma, which included cisplatin, (with or
   without other agents)

   - Patient must have completed cancer treatment >= 2 years prior to study enrollment

   - Osteosarcoma survivors without a systemically treated relapse or subsequent malignancy

      - Note: History of relapse or second malignancy is permitted if treated with local
      therapy only (e.g. surgery, radiation)

   - Able to speak, read and write in English, French or Spanish

   - All patients and/or their parents or legal guardians must sign a written informed
   consent

   - All institutional, Food and Drug Administration (FDA), and National Cancer Institute
   (NCI) requirements for human studies must be met

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study

Male

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Site Public Contact
Recruiting